ALSTON CALDERON: Open Payments
NPI 1023607819 · JENSEN BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$750 in 32 payments from 13 companies in 2025. Trend: 2023 $2,015 · 2024 $2,198 · 2025 $750
Food & beverage: $750
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $160 |
| Teva Pharmaceuticals USA, Inc. | 3 | $107 |
| Alkermes, Inc. | 4 | $79 |
| E.R. Squibb & Sons, L.L.C. | 3 | $78 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
Products named: VRAYLAR, AUSTEDO XR, ARISTADA, COBENFY, Auvelity, TRINTELLIX, REXULTI, INVEGA SUSTENNA.
Industry payments across FL — which companies pay providers there.
